换一批
换一批Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.
作者：
Felix C,Saalfeld [1]
;
Carina,Wenzel [2]
;
Petros,Christopoulos [3]
;
Sabine,Merkelbach-Bruse [4]
;
Timm M,Reissig [5]
;
Silke,Laßmann [6]
;
Sebastian,Thiel [7]
;
Jan A,Stratmann [8]
;
Ralf,Marienfeld [9]
;
Johannes,Berger [10]
;
Alexander,Desuki [11]
;
Janna-Lisa,Velthaus [12]
;
Diego,Kauffmann-Guerrero [13]
;
Albrecht,Stenzinger [14]
;
Sebastian,Michels [15]
;
Thomas,Herold [16]
;
Michael,Kramer [1]
;
Sylvia,Herold [2]
;
Amanda,Tufman [13]
;
Sonja,Loges [17]
;
Jürgen,Alt [11]
;
Maria,Joosten [18]
;
Gerlinde,Schmidtke-Schrezenmeier [19]
;
Martin,Sebastian [8]
;
Susann,Stephan-Falkenau [20]
;
Cornelius F,Waller [21]
;
Marcel,Wiesweg [5]
;
Jürgen,Wolf [15]
;
Michael,Thomas [3]
;
Daniela E,Aust [2]
;
Martin,Wermke [22]
;
National Network Genomic Medicine Lung Cancer (nNGM)
作者单位：
Clinic for Internal Medicine I, University Hospital, Technische Universität Dresden, Dresden, Germany.
[1]
Department for Pathology, University Hospital, Technische Universität Dresden, Dresden, Germany.
[2]
Thoraxklinik at University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
[3]
Institute of Pathology, University Hospital, University of Cologne, Köln, Germany.
[4]
West German Cancer Center, Department of Medical Oncology, University Duisburg-Essen, Essen, Germany.
[5]
Institute for Surgical Pathology, Faculty of Medicine, University Medical Centre Freiburg, University of Freiburg, Freiburg, Germany.
[6]
Department of Pneumology, Helios Clinic Emil von Behring, Berlin, Germany.
[7]
Department of Medicine, Hematology/Oncology, University Hospital, University of Frankfurt, Frankfurt am Main, Germany.
[8]
Institute of Pathology, University Hospital, University of Ulm, Ulm, Germany.
[9]
Charité Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
[10]
Universitäres Centrum für Tumorerkrankungen (UCT) and 3rd Med. Depratment, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
[11]
Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[12]
Division of Respiratory Medicine and Thoracic Oncology, Department of Internal Medicine V, Thoracic Oncology Center Munich, University of Munich (LMU), Munich, Germany.
[13]
Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research (DZL), Heidelberg, Germany; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
[14]
Clinic I for Internal Medicine, University Hospital, University of Cologne, Köln, Germany.
[15]
Department of Pathology, West German Cancer Center, University Hospital Essen, Essen, Germany.
[16]
Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Personalized Oncology, University Hospital Mannheim, Mannheim, Germany.
[17]
Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
[18]
Department of Internal Medicine II, University Medical Center Ulm, Ulm, Germany.
[19]
Department of Pathology, Helios Klinikum Emil von Behring, Berlin, Germany.
[20]
Department of Haematology, Oncology and Stem Cell Transplantation, University Medical Centre Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
[21]
Clinic for Internal Medicine I, University Hospital, Technische Universität Dresden, Dresden, Germany. Electronic address: martin.wermke@uniklinikum-dresden.de.
[22]
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);人类(Humans);肺肿瘤(Lung Neoplasms);突变(Mutation);回顾性研究(Retrospective Studies)
DOI
10.1016/j.jtho.2021.06.025
PMID
34245914
发布时间
2021-11-03
- 浏览2
Journal of thoracic oncology
Journal of thoracic oncology
1952-1958页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
